What makes your innovation unique?
NovoArc is utilising its patented technology to produce unique lipids with extremophilic microorganisms according to pharmaceutical standards. These patent-protected lipids protect active agents in the stomach and during storage, increase bioavailability and thus make it possible to switch from injections to tablets or drops. The scalable technology is revolutionising pharmaceutical formulations.
Advantages
• The technology makes it possible to replace syringes with tablets or drops.
• It is scalable and protected by 3 patents.
Awards
• AWS Best of Biotech – 2023
About the company
NovoArc, founded in 2021 as a spin-off of TU Wien, develops scalable technologies for unique lipids in biopharmaceutical formulations. With 10 RTDs in an approved Viennese production facility, it generates revenue through sales, projects and licences in the field of novel drug administration.
